Alibaba Group and its U.S. payment subsidiary, AUS Merchant Services, agreed on Wednesday to pay $600 million to the Department of Justice. The charges were not trivial. Federal prosecutors alleged that Alibaba's platforms facilitated approximately 80,000 prohibited pharmaceutical transactions shipped into the United States between January 2016 and December 2024, with a total gross merchandise value exceeding $200 million. Controlled substances. Pill presses. Regulated chemicals. For nearly a decade, Alibaba.com and AliExpress served as a pipeline.
The penalty structure reflects how seriously the DOJ treated the case. Alibaba will pay $125 million in criminal fines and forfeit $200 million. AUS Merchant Services, an Ant Group subsidiary that processed payments for the transactions, will pay $85 million in fines and forfeit $190 million. The agreements are non-prosecution deals, not guilty pleas. Alibaba avoided a criminal conviction.
The stock rose 10.8 percent.
Alibaba's American Depositary Receipts closed at $108.78, up from $98.14 the prior session. The single-day gain was the largest since September 2025. Market capitalization climbed to approximately $262 billion, an increase of more than $25 billion. The $600 million fine represented 0.23 percent of the company's market cap. The market cap gained on the news was more than 40 times the fine.
The rally had multiple drivers. UBS analyst Kenneth Fong published a note Wednesday citing a pre-earnings update in which Alibaba described narrowing losses in its instant-commerce business and steady overall profitability. He estimated 45 percent top-line growth in the cloud computing unit for the June quarter, with AI-related revenue sustaining triple-digit expansion. Earnings are scheduled for August 28.
But the analyst note alone does not explain an 11 percent move. The DOJ settlement does. Not because $600 million is a rounding error, though at 0.4 percent of Alibaba's $148.4 billion in trailing twelve-month revenue it comes close. The settlement matters because it converted an open investigation into a closed line item. An investigation has no ceiling. A non-prosecution agreement has a dollar sign and a compliance schedule. Markets can price a line item. They cannot price uncertainty.
The DOJ settlement was one of two legal actions resolved or advanced in the same week. The other cut deeper.
On June 8, the Pentagon added Alibaba to its Section 1260H list of Chinese military companies. The designation did not prohibit Americans from owning the stock. What it did was trigger Section 851 of the fiscal year 2025 National Defense Authorization Act, which bars the Department of Defense from contracting with any company that employs a registered lobbyist representing an entity on the 1260H list. In practice, lobbying firms had to choose between their Chinese clients and their defense clients. They chose defense.
Within weeks, every one of Alibaba's more than twenty registered lobbyists withdrew. Brownstein Hyatt Farber Schreck, Mercury Public Affairs, MO Strategies. The firms that had translated Alibaba's priorities into the language Washington speaks simply stopped answering the phone. Tencent lost its lobbyists through the same mechanism.
On June 23, Alibaba sued the Pentagon in federal court, arguing the designation had no basis in fact or law and violated its constitutional rights to speech and due process. On July 5, U.S. District Judge Eumi K. Lee issued a temporary restraining order suspending the lobbying restriction. The order gives Alibaba 60 days to make its case before the ban is reimposed.
The two legal proceedings point in opposite directions. The DOJ says Alibaba is a company that broke American pharmaceutical law for nine years and must now reform its compliance operations. The Pentagon says Alibaba is a Chinese military company that should be excluded from the American influence system entirely. The DOJ accepted $600 million and offered a compliance framework. The Pentagon offered nothing.
The market added $25 billion and bet on the DOJ.
This is not the first time Alibaba has paid a sovereign for the right to remain legible. In April 2021, China's State Administration for Market Regulation fined the company 18.2 billion yuan, approximately $2.8 billion, for anticompetitive practices. That fine was 4.7 times larger than the DOJ settlement. Alibaba paid it and the stock rallied. The same pattern. The penalty is the resolution. The resolution is worth more than the penalty.
Cloud computing revenue hit approximately $6 billion for the quarter ending in March, growing 38 percent and accelerating from 36 percent the prior quarter. AI-related products within the cloud unit are growing at triple-digit rates. The business Alibaba is building has nothing to do with the business the DOJ just settled. But the settlement determines whether American capital can participate without an asterisk.
The $600 million Alibaba paid on Wednesday was not a fine. It was a receipt. Proof that the company had been processed through the American legal system and emerged on the other side with a compliance agreement rather than a conviction. The market did not rally because the fine was small. It rallied because the fine was final.